The Swiss Industrial Biocatalysis Consortium (SIBC) turns 20!

Authors

  • Serena Bisagni Pharmaceutical Division, Synthetic Molecules Technical Development, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, Switzerland
  • Fabian Eggimann Novartis Biomedical Research, Global Discovery Chemistry, Basel, CH-4108
  • Eric Eichhorn Givaudan Schweiz AG, Kemptpark 50, CH-8310 Kemptthal, Switzerland https://orcid.org/0000-0003-2113-6305
  • Steven Hanlon Pharmaceutical Division, Synthetic Molecules Technical Development, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, Switzerland
  • Hans Iding Division, Synthetic Molecules Technical Development, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, Switzerland
  • Alberto Kravina Lonza, Lonzastrasse, CH-3930 Visp, Switzerland
  • Camille Le Chapelain Syngenta Crop Protection AG, Schaffhauserstr. 101, CH-4332 Stein, Switzerland https://orcid.org/0000-0001-5347-6035
  • Katharina Neufeld Johnson & Johnson Innovative Medicine, Chemical Process R&D, Turnhoutseweg 30, B-2340 Beerse, Belgium
  • Lukas Rigger Reference Materials R&D, Merck KGaA, Sigma-Aldrich Production GmbH, Industriestrasse 25, CH-9470 Buchs, Switzerland https://orcid.org/0009-0006-4107-6046
  • Kirsten Schroer Chemical and Analytical Development, Novartis Pharma AG, CH-4056 Basel, Switzerland
  • Radka Snajdrova Novartis Biomedical Research, Global Discovery Chemistry, Basel, CH-4108
  • Elina Siirola Novartis Biomedical Research, Global Discovery Chemistry, Basel, CH-4108

DOI:

https://doi.org/10.2533/chimia.2025.299

PMID:

40439609

Abstract

In 2024, the Swiss Industrial Biocatalysis Consortium (SIBC), celebrated its 20 years of bringing together experts from the pharma, flavor and fragrance, fine chemicals, and agrochemicals industries to discuss enzyme technology developments. In this perspective, we share recent examples of how our member organizations utilize biocatalysis in their respective industries. While the motivations for employing enzymatic synthesis and the end goals of various production processes may vary, we aim to emphasize the shared aspects that we are coming across. Over the past 20 years, those synergies have provided us with a fruitful basis for pre-competitive knowledge sharing around biocatalysis as a technology. We look forward to many more years of the SIBC and the surprises that await us through the potential of our enzymes.

CHIMIA Vol. 79 No. 5 (2025): Biomanufacturing

Downloads

Published

2025-05-28

Issue

Vol. 79 No. 5 (2025): Biomanufacturing

Section

Scientific Articles

License

Copyright (c) 2025 Serena Bisagni, Fabian Eggimann, Eric Eichhorn, Steven Hanlon, Hans Iding, Alberto Kravina, Camille Le Chapelain, Katharina Neufeld, Lukas Rigger, Kirsten Schroer, Radka Snajdrova, Elina Siirola

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
S. Bisagni, F. Eggimann, E. Eichhorn, S. Hanlon, H. Iding, A. Kravina, C. Le Chapelain, K. Neufeld, L. Rigger, K. Schroer, R. Snajdrova, E. Siirola, Chimia 2025, 79, 299, DOI: 10.2533/chimia.2025.299.